secwatch.observer — SEC 8-K summary
======================================

Issuer:     BeyondSpring Inc. (BYSI)
CIK:        0001677940
Form:       8-K
Filed at:   2025-02-25T23:59:59+00:00
Accession:  0001171843-25-001050
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.78
Item codes: 2.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

BeyondSpring closes first tranche of SEED Therapeutics stake sale for $7.4M; total deal $35.4M
--------------------------------------------------------------------------------

- First closing transferred 1,730,454 SEED Series A-1 Preferred Shares for $7,354,433 cash.
- Amendment added 230,400 shares to Winning View for $979,203; total purchase price unchanged at ~$35.4M.
- BYSI ownership in SEED fell from 46.87% to 40.12%; control retained until second closing expected by Dec 2025.
- Pro forma gain on disposition of SEED estimated at $67.5M; SEED classified as discontinued operations.
- Remaining 6,603,183 shares to be sold in two closings through 2026; no assurance of completion.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1677940/000117184325001050/0001171843-25-001050-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1677940/000117184325001050/f8k_022425.htm
  HTML page:      https://secwatch.observer/filing/0001171843-25-001050

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer